Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Cutaneous Sarcoidosis
NCT00274352Phase 2Completed
- Start
- Sep 2006
- Primary completion
- Feb 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in cutaneous sarcoidosis. Started Sep 2006; status: completed.
02
Drugs
03
Conditions
cutaneous sarcoidosis
Beyond the preview
Go deeper on NCT00274352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274352.